Exelixis

This study tested a drug called XL184 in 19 people whose grade IV astrocytic brain tumors had come back after initial treatment. The goal was to see if the drug could shrink tumors or slow their growth. However, the company stopped the study early for business reasons, so no clea…

This study tested a combination of two drugs, cabozantinib and abiraterone, in men with a type of advanced prostate cancer that had spread to the bones and no longer responded to standard hormone therapy. The goal was to see if the combination could delay cancer growth or death. …